In patients with colorectal cancer, JAK1 overexpression was significantly correlated with reduced survival, and the inhibition of JAK1 protein expression can impede cancer cell proliferation and progression, thereby effectively treating tumors (25). This evidence concerns the gene JAK1 and colorectal cancer.